{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T11:12:00Z","timestamp":1794741120442,"version":"4.9.1"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,7]],"date-time":"2025-02-07T00:00:00Z","timestamp":1738886400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100018296","name":"Fort\u00e9 Foundation","doi-asserted-by":"publisher","award":["2020-00029"],"award-info":[{"award-number":["2020-00029"]}],"id":[{"id":"10.13039\/100018296","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["R01AG056479-01"],"award-info":[{"award-number":["R01AG056479-01"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004359","name":"Swedish Research Council","doi-asserted-by":"publisher","award":["2021-02236"],"award-info":[{"award-number":["2021-02236"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jclinepi.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Epidemiology"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.jclinepi.2025.111716","type":"journal-article","created":{"date-parts":[[2025,2,7]],"date-time":"2025-02-07T11:24:57Z","timestamp":1738927497000},"page":"111716","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Using methods to extend inferences to specific target populations to improve the precision of subgroup analyses"],"prefix":"10.1016","volume":"181","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8079-8504","authenticated-orcid":false,"given":"Michael","family":"Webster-Clark","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1290-271X","authenticated-orcid":false,"given":"Anthony A.","family":"Matthews","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7659-6969","authenticated-orcid":false,"given":"Alan R.","family":"Ellis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4279-8685","authenticated-orcid":false,"given":"Alan C.","family":"Kinlaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5981-8443","authenticated-orcid":false,"given":"Robert W.","family":"Platt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jclinepi.2025.111716_bib1","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1093\/icvts\/ivaa042","article-title":"A statistical pri-mer on subgroup analyses","volume":"30","author":"Milojevic","year":"2020","journal-title":"Interact Cardiovasc Thorac Surg"},{"key":"10.1016\/j.jclinepi.2025.111716_bib2","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s11121-011-0221-x","article-title":"Detecting moderator effects using subgroup analyses","volume":"14","author":"Wang","year":"2013","journal-title":"Prev Sci"},{"key":"10.1016\/j.jclinepi.2025.111716_bib3","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1097\/EDE.0b013e3181ba333c","article-title":"On the distinction between interaction and effect modification","volume":"20","author":"VanderWeele","year":"2009","journal-title":"Epidemiology"},{"key":"10.1016\/j.jclinepi.2025.111716_bib4","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1056\/NEJMsr077003","article-title":"Statistics in medicine\u2014reporting of subgroup analyses in clinical trials","volume":"357","author":"Wang","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jclinepi.2025.111716_bib5","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1093\/aje\/kwaa185","article-title":"Directed acyclic graphs, effect measure modification, and generalizability","volume":"190","author":"Webster-Clark","year":"2021","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.jclinepi.2025.111716_bib6","series-title":"Modern epidemiology","author":"Rothman","year":"2008"},{"key":"10.1016\/j.jclinepi.2025.111716_bib7","article-title":"Three simple rules to ensure reasonably credible subgroup analyses","volume":"351","author":"Burke","year":"2015","journal-title":"BMJ Br Med J (Clin Res Ed)"},{"key":"10.1016\/j.jclinepi.2025.111716_bib8","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/S0140-6736(00)02031-6","article-title":"From star signs to trial guidelines","volume":"355","author":"Horton","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.jclinepi.2025.111716_bib9","series-title":"Probabilistic and causal inference: The works of Judea Pearl","first-page":"451","article-title":"External validity: from do-calculus to transportability across populations","author":"Pearl","year":"2022"},{"key":"10.1016\/j.jclinepi.2025.111716_bib10","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1146\/annurev-statistics-042522-103837","article-title":"A review of generalizability and transportability","volume":"10","author":"Degtiar","year":"2023","journal-title":"Ann Rev Statistics Appl"},{"key":"10.1016\/j.jclinepi.2025.111716_bib11","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1097\/EDE.0000000000001694","article-title":"Visualizing external validity: graphical displays to inform the extension of treatment effects from trials to clinical practice","volume":"35","author":"Lund","year":"2024","journal-title":"Epidemiology"},{"key":"10.1016\/j.jclinepi.2025.111716_bib12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/epirev\/mxac011","article-title":"Using trial and observational data to assess effectiveness: trial emulation, transportability, benchmarking, and joint analysis","volume":"46","author":"Dahabreh","year":"2023","journal-title":"Epidemiol Rev"},{"key":"10.1016\/j.jclinepi.2025.111716_bib13","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1007\/s10654-019-00533-2","article-title":"Extending inferences from a randomized trial to a target population","volume":"34","author":"Dahabreh","year":"2019","journal-title":"Euro J Epidemiol"},{"key":"10.1016\/j.jclinepi.2025.111716_bib14","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1007\/s10654-019-00532-3","article-title":"New methods for generalizability and transportability: the new norm","volume":"34","author":"Mumford","year":"2019","journal-title":"Eur J Epidemiol"},{"key":"10.1016\/j.jclinepi.2025.111716_bib15","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1093\/aje\/kwq084","article-title":"Generalizing evidence from randomized clinical trials to target populations: the ACTG 320 trial","volume":"172","author":"Cole","year":"2010","journal-title":"American journal of epidemiology"},{"key":"10.1016\/j.jclinepi.2025.111716_bib16","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1097\/EDE.0000000000001230","article-title":"Reweighting oranges to apples: transported RE-LY trial versus nonexperimental effect estimates of anticoagulation in atrial fibrillation","volume":"31","author":"Webster-Clark","year":"2020","journal-title":"Epidemiology"},{"key":"10.1016\/j.jclinepi.2025.111716_bib17","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1111\/biom.13716","article-title":"Efficient and robust methods for causally interpretable meta-analysis: transporting inferences from multiple randomized trials to a target population","volume":"79","author":"Dahabreh","year":"2023","journal-title":"Biometrics"},{"key":"10.1016\/j.jclinepi.2025.111716_bib18","series-title":"Center-specific causal inference with multicenter trials: reinterpreting trial evidence in the context of each participating center","author":"Robertson","year":"2021"},{"key":"10.1016\/j.jclinepi.2025.111716_bib19","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1093\/aje\/kwae015","article-title":"Standardizing to specific target populations in distributed networks and multi-site pharmacoepidemiologic studies","volume":"193","author":"Webster-Clark","year":"2024","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.jclinepi.2025.111716_bib20","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1093\/aje\/kwac036","article-title":"Estimating subgroup effects in generalizability and transportability analyses","volume":"193","author":"Robertson","year":"2022","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.jclinepi.2025.111716_bib21","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1093\/annonc\/mdu141","article-title":"Final results from PRIME: randomized phase III study of panitumumab with FOLFOX4 for first-line treatment of metastatic colorectal cancer","volume":"25","author":"Douillard","year":"2014","journal-title":"Ann Oncol"},{"key":"10.1016\/j.jclinepi.2025.111716_bib22","doi-asserted-by":"crossref","first-page":"4697","DOI":"10.1200\/JCO.2009.27.4860","article-title":"Randomized, phase III trial of panitumumab with infusional fluorouracil, leucovorin, and oxaliplatin (FOLFOX4) versus FOLFOX4 alone as first-line treatment in patients with previously untreated metastatic colorectal cancer: the PRIME study","volume":"28","author":"Douillard","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jclinepi.2025.111716_bib23","doi-asserted-by":"crossref","first-page":"680","DOI":"10.7326\/0003-4819-154-10-201105170-00008","article-title":"Interpretation of subgroup analyses in randomized trials: heterogeneity versus secondary interventions","volume":"154","author":"VanderWeele","year":"2011","journal-title":"Ann Int Med"},{"key":"10.1016\/j.jclinepi.2025.111716_bib24","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1093\/aje\/kwad041","article-title":"How choice of effect measure influences minimally sufficient adjustment sets for external validity","volume":"192","author":"Webster-Clark","year":"2023","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.jclinepi.2025.111716_bib25","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.jclinepi.2020.06.020","article-title":"How subgroup analyses can miss the trees for the forest plots: a simulation study","volume":"126","author":"Webster-Clark","year":"2020","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.jclinepi.2025.111716_bib26","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1097\/EDE.0b013e3182109296","article-title":"Compound treatments and transportability of causal inference","volume":"22","author":"Hern\u00e1n","year":"2011","journal-title":"Epidemiology"},{"key":"10.1016\/j.jclinepi.2025.111716_bib27","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1080\/01621459.2016.1260466","article-title":"Balancing covariates via propensity score weighting","volume":"113","author":"Li","year":"2018","journal-title":"J Am Stat Assoc"},{"key":"10.1016\/j.jclinepi.2025.111716_bib28","doi-asserted-by":"crossref","first-page":"3661","DOI":"10.1002\/sim.6607","article-title":"Moving towards best practice when using inverse probability of treatment weighting (IPTW) using the propensity score to estimate causal treatment effects in observational studies","volume":"34","author":"Austin","year":"2015","journal-title":"Stat Med"},{"key":"10.1016\/j.jclinepi.2025.111716_bib29","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1093\/aje\/kwx164","article-title":"Transportability of trial results using inverse odds of sampling weights","volume":"186","author":"Westreich","year":"2017","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.jclinepi.2025.111716_bib30","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1177\/01632780122034885","article-title":"Simple pooling versus combining in meta-analysis","volume":"24","author":"Bravata","year":"2001","journal-title":"Eval Health Prof"},{"key":"10.1016\/j.jclinepi.2025.111716_bib31","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1111\/rssa.12275","article-title":"A re-evaluation of fixed effect (s) meta-analysis","volume":"181","author":"Rice","year":"2018","journal-title":"J Roy Stat Soc Stat Soc"},{"key":"10.1016\/j.jclinepi.2025.111716_bib32","first-page":"26","article-title":"Research progress on KRAS mutations in colorectal cancer","volume":"7","author":"Marco","year":"2021","journal-title":"J Cancer Metastasis Treat"},{"key":"10.1016\/j.jclinepi.2025.111716_bib33","first-page":"114","article-title":"Cancer outcomes in hispanics\/latinos in the United States: an integrative review and conceptual model of determinants of health","volume":"4","author":"Yanez","year":"2016","journal-title":"J Lat Psychol"},{"key":"10.1016\/j.jclinepi.2025.111716_bib34","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1093\/ckj\/sfab158","article-title":"An introduction to inverse probability of treatment weighting in observational research","volume":"15","author":"Chesnaye","year":"2022","journal-title":"Clin Kidney J"},{"key":"10.1016\/j.jclinepi.2025.111716_bib35","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1111\/biom.13009","article-title":"Generalizing causal inferences from individuals in randomized trials to all trial-eligible individuals","volume":"75","author":"Dahabreh","year":"2018","journal-title":"Biometrics"},{"key":"10.1016\/j.jclinepi.2025.111716_bib36","series-title":"Data Integration Approaches to Estimate Heterogenous Treatment Effects","author":"Brantner","year":"2024"},{"key":"10.1016\/j.jclinepi.2025.111716_bib37","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1002\/sim.9955","article-title":"Comparison of methods that combine multiple randomized trials to estimate heterogeneous treatment effects","volume":"43","author":"Brantner","year":"2024","journal-title":"Stat Med"},{"key":"10.1016\/j.jclinepi.2025.111716_bib38","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1177\/0962280210394469","article-title":"Using causal diagrams to guide analysis in missing data problems","volume":"21","author":"Daniel","year":"2012","journal-title":"Stat Methods Med Res"},{"key":"10.1016\/j.jclinepi.2025.111716_bib39","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1093\/aje\/kwr458","article-title":"Results on differential and dependent measurement error of the exposure and the outcome using signed directed acyclic graphs","volume":"175","author":"VanderWeele","year":"2012","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.jclinepi.2025.111716_bib40","series-title":"Causal Inference: What If","author":"Hernan","year":"2024"},{"key":"10.1016\/j.jclinepi.2025.111716_bib41","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1742-5573-4-4","article-title":"Power for tests of interaction: effect of raising the Type I error rate","volume":"4","author":"Marshall","year":"2007","journal-title":"Epidemiol Perspect Innovat"},{"key":"10.1016\/j.jclinepi.2025.111716_bib42","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1097\/EDE.0000000000000354","article-title":"Is the risk difference really a more heterogeneous measure?","volume":"26","author":"Poole","year":"2015","journal-title":"Epidemiology"},{"key":"10.1016\/j.jclinepi.2025.111716_bib43","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1177\/096228020101000404","article-title":"Bayesian methods in meta-analysis and evidence synthesis","volume":"10","author":"Sutton","year":"2001","journal-title":"Stat Methods Med Res"},{"key":"10.1016\/j.jclinepi.2025.111716_bib44","series-title":"Advances in Experimental Political Science","first-page":"271","article-title":"Subgroup analysis: pitfalls, promise, and honesty","author":"Ratkovic","year":"2021"}],"container-title":["Journal of Clinical Epidemiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0895435625000496?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0895435625000496?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T20:09:04Z","timestamp":1777579744000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0895435625000496"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":44,"alternative-id":["S0895435625000496"],"URL":"https:\/\/doi.org\/10.1016\/j.jclinepi.2025.111716","relation":{},"ISSN":["0895-4356"],"issn-type":[{"value":"0895-4356","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Using methods to extend inferences to specific target populations to improve the precision of subgroup analyses","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Epidemiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jclinepi.2025.111716","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"111716"}}